Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisChristopher Seymour, Derek C. Angus, Jason Kennedy et al.|JAMA|2019Cited by 1.5k
Sepsis Subclasses: A Framework for Development and Interpretation*Kimberley M. DeMerle, Christopher W. Seymour, Nathan I. Shapiro et al.|Critical Care Medicine|2021Cited by 171
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant SurgeDavid T. Huang, Christopher Seymour, Erin K McCreary et al.|JAMA Network Open|2022Cited by 54
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trialErin K McCreary, David T. Huang, J Ryan Bariola et al.|Contemporary Clinical Trials|2022Cited by 26
Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patientsKatherine M. Reitz, Matthew D. Neal, Christopher Seymour et al.|BMJ Open|2020Cited by 18